4baseCare Partners With Caritas Hospitals to Bring Personalised Cancer Care to Kerala

In a major boost to advanced oncology services in Kerala, Caritas Hospitals has partnered with precision oncology company 4baseCare to deliver personalised, genomics-driven cancer care to patients in Kottayam and neighbouring regions. The collaboration aims to make cutting-edge cancer diagnostics and targeted therapies more accessible, improving outcomes while reducing unnecessary side effects.

Advancing Precision Oncology at the Regional Level

Through this partnership, clinicians at Caritas Hospitals will be able to leverage genetic testing to better understand the unique biology of each patient’s cancer. By analysing tumour-specific genetic markers, doctors can recommend treatments that are more targeted and effective, while avoiding therapies that may offer limited benefit or cause excessive toxicity.

The initiative brings personalised, data-driven cancer care closer to patients who previously had limited access to advanced genomic testing. It also helps bridge the gap between clinical research and real-world treatment, ensuring that scientific advances translate into tangible benefits for patients across Kerala.

Expanding Access to Genomic Testing and Targeted Therapies

As part of the collaboration, 4baseCare will support the expansion of genomic testing infrastructure and precision oncology services at Caritas Hospitals. This will enable oncologists to make evidence-based treatment decisions informed by population-relevant genomic data, an area that has historically been underrepresented in global cancer research.

By integrating advanced genomics into routine clinical practice, the partnership seeks to improve treatment precision, enhance quality of life, and support more informed decision-making throughout a patient’s cancer journey.

Rev Dr Binu Kunnath, Director and CEO of Caritas Hospitals, said the partnership reflects the institution’s commitment to compassionate and clinically advanced care.

“At Caritas Hospitals, our focus has always been on delivering care that is compassionate, credible, and clinically advanced. This partnership with 4baseCare strengthens our ability to offer patients truly personalised cancer care, guided by science, driven by data, and delivered with empathy,” he said.

“By integrating advanced genomics into everyday clinical practice, we are expanding access to modern cancer care and improving outcomes for patients and families across the region.”

Hitesh Goswami, CEO and Co-Founder of 4baseCare, highlighted the broader impact of the collaboration on India’s oncology landscape. “Bringing advanced genomics and precision oncology capabilities to Caritas Hospitals is another important step toward patient-centric cancer care in India,” he said. “This collaboration moves us closer to a future where every cancer patient can receive treatment that is timely, targeted, and tailored to their individual disease biology.”

Strengthening the Future of Cancer Care in Kerala

With cancer incidence rising across India, the demand for personalised and effective treatment options continues to grow. The 4baseCare–Caritas partnership positions Kerala as a leader in adopting precision oncology at the regional level, ensuring patients no longer need to travel far for advanced cancer diagnostics and care.